Papers

7

Total Citations

76

H-Index

5

About

Dr. Bastian Amend is a pioneering surgeon and researcher at the forefront of urologic oncology and robotic-assisted surgery. His work centers on refining the diagnosis and treatment of prostate cancer, with a major focus on improving biopsy accuracy and surgical outcomes. Dr. Amend has made seminal contributions to the field of targeted prostate biopsy, demonstrating in his highly cited 2017 study (33 citations) the performance of robot-assisted transperineal fusion biopsies, a technique that significantly enhances the detection of clinically significant cancer compared to systematic approaches. He further validated novel imaging methods, including a first-of-its-kind robotic transrectal computed tomographic ultrasound combined with artificial neural network analysis, offering a promising alternative when high-quality MRI is unavailable. Beyond oncology, Dr. Amend has innovated in surgical technique, developing a peritoneal purse-string suture to prevent symptomatic lymphoceles after Retzius-sparing robotic prostatectomy. Demonstrating remarkable cross-disciplinary skill, he has also applied robotic precision to orthopedic trauma, pioneering robot-assisted osteosynthesis for pelvic ring and acetabular fractures. With a portfolio of over 75 citations, Dr. Amend’s work is defining the next generation of minimally invasive, high-precision surgery.

Research Focus

Key Achievements

5
H-Index
7
Papers
76
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Targeted vs systematic robot‐assisted transperineal magnetic resonance imaging‐transrectal ultrasonography fusion prostate biopsy
33 citations · 2017
📈 Most Prolific Year: 2017 (2 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: University of Tübingen, University Children's Hospital Tübingen

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago